IBKR vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

IBKR

52.7
AI Score
VS
IBKR Wins

CME

45.0
AI Score

Investment Advisor Scores

IBKR

53score
Recommendation
HOLD

CME

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IBKR CME Winner
Forward P/E 28.5714 22.2222 CME
PEG Ratio 1.5005 4.7658 IBKR
Revenue Growth 26.3% 0.8% IBKR
Earnings Growth 35.3% 2.5% IBKR
Tradestie Score 52.7/100 45.0/100 IBKR
Profit Margin 16.5% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IBKR 1M: -0.3% · 3M: +2.9% CME 1M: +5.1% · 3M: +5.1%

Current Technical Phase

IBKR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $91.37

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 53

RSI (14): 53.1 · Price: $275.54

Fundamentals Snapshot

Metric IBKR CME
Market Cap
Forward P/E 28.7 21.3
Trailing P/E 35.9 23.3
Revenue (TTM)
Revenue Growth 0.3% 0.0%
Gross Margin 0.9% 1.0%
Operating Margin 0.8% 0.7%
EPS 2.49 11.78
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, IBKR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.